Cabtreo NDC 0187-0006

NDC codes

FDA NDC Directory

Product NDC (as listed)0187-0006Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00187-0006Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
0187-0006-10	00187000610	1 BOTTLE, PUMP in 1 CARTON (0187-0006-10) / 20 g in 1 BOTTLE, PUMPMarketed from Oct 20, 2023
0187-0006-25	00187000625	1 BOTTLE, PUMP in 1 CARTON (0187-0006-25) / 50 g in 1 BOTTLE, PUMPMarketed from Oct 20, 2023
0187-0006-35	00187000635	3.5 g in 1 TUBE (0187-0006-35)Marketed from Oct 20, 2023 · Sample package

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cabtreo
Generic name (nonproprietary): clindamycin phosphate/benzoyl peroxide/adapalene
Active ingredients: Clindamycin phosphate — 12 mg/gBenzoyl peroxide — 31 mg/gAdapalene — 1.5 mg/g
Dosage form: Gel
Route: Topical
Labeler: Bausch Health US LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 216632
Marketing start: Oct 20, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Lincosamides (Chemical structure)Neuromuscular Blockade (Physiologic effect)Retinoids (Chemical structure)
Identifiers: Product ID 0187-0006_338bc721-434d-cbc2-e063-6394a90abc47SPL ID 338bc721-434d-cbc2-e063-6394a90abc47SPL set ID 9468da0f-9978-4c58-8135-0274c3415084RxCUI 2668198, 2668204UNII EH6D7113I8, W9WZN9A0GM, 1L4806J2QF
Pharmacologic class: Lincosamide Antibacterial; Retinoid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400187000610 followed by a unit qualifier and the quantity

Package 00187-0006-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 24, 2025.

Indications (excerpt from the label)

CABTREO is indicated for the topical treatment of acne vulgaris in adult and pediatric patients 12 years of age and older. CABTREO is a combination of clindamycin phosphate (a lincosamide antibacterial), adapalene (a retinoid), and benzoyl peroxide indicated for the topical treatment of acne vulgaris in adult and pediatric patients 12 years of age and older. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)